Clinical Trials Sponsored by Osivax

Total 46 results

Osivax
Aepodia

Completed

Safety and Immune Response of Increasing Doses of OVX836 After Intramuscular or Intranasal Administrations in Healthy Subjects

Influenza

Belgium
Osivax
Hôpital Cochin; Clinact

Not yet recruiting

Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg

Influenza
Abivax S.A.

Completed

ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

Ulcerative Colitis

Belgium
Abivax S.A.

Completed

Safety and Pharmacokinetics Study in Healthy Japanese Volunteers

Healthy Volunteers

Japan
Abivax S.A.

Terminated

ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19 (Mir-Age)

COVID-19

Spain, Belgium, United Kingdom, Germany, France, Brazil, Italy, Mexico
Abivax S.A.

Completed

ABX464 in Fully Controlled HIV Infected Patients Treated With Boosted Protease Inhibitor Treatment

HIV Infection

Spain, Belgium, France
Abivax S.A.

Completed

Clinical Efficacy of ABX203 Therapeutic Vaccine in HBeAg Negative Patients With Chronic Hepatitis B

Chronic Hepatitis B

New Zealand, Australia
Abivax S.A.

Recruiting

ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2

Ulcerative Colitis

United States, Spain, Italy, Croatia, Israel, Japan, Romania, Belgium, New Zealand, India, Hungary, France, Poland, United Kingdom, Czechia, Mexico, Germany, Bulgaria, Brazil, Slovakia, Serbia, Lithuania, Argentina, Canada, Ireland
Abivax S.A.

Recruiting

ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

Ulcerative Colitis

Belgium, United States, Korea, Republic of, Australia, Austria, Italy, Netherlands, Spain, United Kingdom, China, France, Greece, Germany, Switzerland, Canada, India, Turkey, Portugal, Poland, Hungary, Bulgaria, Argentina, Czechia
Abivax S.A.

Completed

Study Evaluating the Long-Term Safety and Efficacy of ABX464 in Patients With Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

Belgium, France, Czechia, Hungary, Poland
Abivax S.A.

Completed

Safety, PK and PD Study of ABX464 in Untreated HIV Patients

Human Immunodeficiency Virus Infections

Thailand, Mauritius
Osivax
Novotech (Australia) Pty Limited; Mater Misericordiae Limited

Completed

Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects.

Influenza

Australia
Osivax
Center for vaccinology (CEVAC), University of Ghent

Completed

Immunogenicity and Safety of Three Dose Levels of OVX836 Candidate Vaccine Against Influenza in Healthy Volunteers.

Influenza

Belgium
Osivax
Centre for vaccinology (CEVAC), University of Ghent

Completed

Safety and Immune Response of One Dose of OVX836 at Two Dose Levels, in Comparison to Influvac TetraTM, After Intramuscular Administration in Healthy Subjects Aged 18-65 Years

Influenza

Belgium
Abivax S.A.

Recruiting

ABTECT - Maintenance

Ulcerative Colitis

United States, Belgium, Korea, Republic of, Australia, Austria, Italy, Spain, China, Israel, Bosnia and Herzegovina, Croatia, Czechia, Japan, Mexico, Netherlands, Romania, Turkey, United Kingdom, Canada, New Zealand, Hungary, India, Franc... and more
Abivax S.A.

Active, not recruiting

Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

Ulcerative Colitis

Belgium, Poland, Czechia, Hungary
Abivax S.A.

Completed

A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults

HIV Infections | Health Volunteers

Spain
Abivax S.A.

Completed

Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

Belgium, France, Czechia, Hungary, Poland
Abivax S.A.

Completed

Evaluation of the Potential CYP1A2-mediated Drug Drug Interaction Safety, and Tolerability of ABX464

Healthy

United Kingdom
Abivax S.A.

Active, not recruiting

Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis

Ulcerative Colitis

Poland, Spain, France, Germany, Italy, Slovenia, Belgium, Canada, Belarus, Hungary, Czechia, Austria, United Kingdom, Serbia, Slovakia, Ukraine
Abivax S.A.

Completed

Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis

Ulcerative Colitis

Belgium, Poland, Spain, France, Germany, Italy, Slovenia, Canada, Belarus, Hungary, Czechia, Austria, United Kingdom, Serbia, Slovakia, Ukraine, United States
Abivax S.A.

Unknown

Safety Evaluation of ABX464 in Patients With Moderate to Severe Active Crohn's Disease

Crohn Disease

Belgium
Abivax S.A.

Completed

ABX464 First in Man Study

Healthy Volunteers

France
Abivax S.A.

Completed

Food Effect on Pharmacokinetic Parameters of ABX464

Healthy Volunteers

Mauritius
Osivax
Center for vaccinology (CEVAC), University of Ghent, Belgium

Completed

A Prospective Epidemiological Cohort Study Evaluating Occurrences of Influenza-like Illness.

Influenza

Belgium
Osivax
Novotech (Australia) Pty Limited; Harmony Clinical Research; Northern Beaches...

Completed

Immunogenicity and Safety of the Concomitant Administration of OVX836 and Quadrivalent Influenza Vaccine in Healthy Volunteers.

Influenza

Australia
Abivax S.A.
C3 Research Associates

Recruiting

ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma

Carcinoma, Hepatocellular

United States
Onyvax

Unknown

Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

Colorectal Cancer

United Kingdom
Sivan Kinberg

Withdrawn

Compassionate Use of Omegaven IV Fat Emulsion

Total Parenteral Nutrition-induced Cholestasis

United States
Weprom
Takeda; SIVAN Innovation

Terminated

Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or Partial Response

Lymphoma, Large B-Cell, Diffuse | Lymphoma, T-Cell | Lymphoma, Hodgkin

France
Weprom
SIVAN Innovation Ldt

Completed

SENTINEL : Impact of the Use of a Web-application for the Detection of Lung Cancer Relapse (SENTINEL)

Lung Cancer

France
Abivax S.A.
Orion Corporation, Orion Pharma

Active, not recruiting

Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis

Ulcerative Colitis

Belgium
Siva Health AG

Enrolling by invitation

Validation Study With a Non-CE Marked Medical Device (MD)

Chronic Cough

United States
Marcelo Alberto OLIVA

Completed

Effectiveness of the Tiger Catheter on Transradial Coronariography: Randomized Compared to JudKins cathETers (TICKET)

Acute Coronary Syndrome

Argentina
Osivax
Centre for the Evaluation of Vaccination Hôpital Cochin Assistance Publique...

Recruiting

First-in-human Study to Evaluate the Safety and Immunogenicity of Three Dose Levels of the OVX033 Coronavirus Vaccine Candidate in Healthy Volunteers

Coronavirus

France
Siva Mulpuru

Terminated

Renal Denervation Therapy in Hypertensive Patients Undergoing A-Fib Ablation

Hypertension | Atrial Fibrillation

United States
Oviva UK Ltd
University of Westminster

Active, not recruiting

The DR-EAM Type 2 Diabetes Study

Type 2 Diabetes

United Kingdom
Kaunas University of Medicine
Pharmacosmos A/S; Orivas, Lithuania

Unknown

Intravenous Iron for Correction of Anaemia After Colorectal Surgery

Colorectal Neoplasms | Anemia, Iron-Deficiency | Colorectal Surgery | Intravenous Drug Usage

Lithuania
UNC Lineberger Comprehensive Cancer Center
Sivan Innovation Ltd.

Completed

Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare® (LC-PRO)

Lung Cancer | Neoplasms, Lung | Pulmonary Neoplasms | Neoplasms, Pulmonary | Pulmonary Cancer | Cancer of Lung

United States
Osias Francisco de Souza

Unknown

Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of Lucentis

Degeneration of Macula and Posterior Pole

Brazil
Univax Biologics Inc

Completed

A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS Patients

HIV Infections | Cryptosporidiosis

United States
Oviva UK Ltd
Guy's and St Thomas' NHS Foundation Trust

Active, not recruiting

The Transform Type 2 Diabetes Study (Transform)

Type2diabetes

United Kingdom
Oviva UK Ltd
University College, London; Hull University Teaching Hospitals NHS Trust

Recruiting

SAFE-LCD Trial, for Insulin-treated Adults Living With Type 2 Diabetes

Type 2 Diabetes Treated With Insulin | Diet Habit

United Kingdom
Oviva AG
Bern University of Applied Sciences; Swiss Commission for Technology and Innovation and other collaborators

Completed

Weight-loss Treatment Through Smartphone-assisted Dietary Coaching (Oviva)

Obesity | Overweight

Switzerland
Kosuyolu Heart Hospital
Kocaeli University; Sakarya University; Sabanci University; Maras Necip Fazil City... and other collaborators

Completed

Adherence to Palivizumab Prophylaxis

Congenital Heart Disease in Children | RSV

Turkey
Fondazione Policlinico Universitario Agostino Gemelli...
Prof. Massimo Cordaro; Dr. Romeo Patini; Dr. Oliva Giorgio; Dr. Candida Ettore; Dr... and other collaborators

Completed

Efficacy of Maxillo-facial Treatment on Cleft Lip and Palate Patients Faces: Aesthetic Considerations

Cicatrix | Cleft Lip and Palate | Randomized Controlled Trial | Growth and Development

Italy

Clinical Trials Sponsored by Osivax

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations